Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymostimulin in malignant pleural effusions.

R Rimoldi, F Brunetta, M Fioretti

    International Journal of Tissue Reactions
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hearing loss in very preterm infants: should we wait or treat?

    Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2019
    Same author

    Effects of potential neurotoxic pesticides on hearing loss: a review.

    Neurotoxicology·2014
    Same author

    Optical coherence tomography in bioabsorbable stents: mechanism of vascular response and guidance of stent implantation.

    Minerva cardioangiologica·2014
    Same author

    Location of side branch access critically affects results in bifurcation stenting: Insights from bench modeling and computational flow simulation.

    International journal of cardiology·2013
    Same author

    Poststreptococcal glomerulonephritis and rheumatic fever: two faces of the same coin.

    European review for medical and pharmacological sciences·2013
    Same author

    Five-year survival of stage IIIA-IIIB (non-N3) non-small cell lung cancer patients after platinum/gemcitabine induction chemotherapy and surgery.

    Journal of chemotherapy (Florence, Italy)·2010
    Same journal

    Effects of D-003 (5-200 mg/kg), a mixture of high molecular weight aliphatic acids from sugarcane wax, on bones and bone cell apoptosis in ovariectomized rats.

    International journal of tissue reactions·2006
    Same journal

    Effect of D-004, a lipid extract from Cuban royal palm fruit, on histological changes of prostate hyperplasia induced with testosterone in rats.

    International journal of tissue reactions·2006
    Same journal

    Pigment epithelium-derived factor is a pericyte mitogen secreted by microvascular endothelial cells: possible participation of angiotensin II-elicited PEDF downregulation in diabetic retinopathy.

    International journal of tissue reactions·2006
    Same journal

    Minodronate, a nitrogen-containing bisphosphonate, inhibits advanced glycation end product-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation.

    International journal of tissue reactions·2006
    Same journal

    Tissue reaction at the implantation of recombinant human bone morphogenetic protein-2 into the skeletal muscle.

    International journal of tissue reactions·2006
    Same journal

    Increasing incidence of melanoma in central Greece: a retrospective epidemiological study.

    International journal of tissue reactions·2006
    See all related articles

    Intrapleural thymostimulin (TS) effectively palliated neoplastic pleural effusions in most patients. This thymic hormone preparation demonstrated rapid, efficient, and non-toxic treatment for malignant pleural effusions.

    Area of Science:

    • Oncology
    • Immunology
    • Thoracic Medicine

    Background:

    • Neoplastic pleural effusion is a common complication of various cancers.
    • Current treatment options for malignant pleural effusion can be invasive and toxic.
    • Palliation of symptoms associated with malignant pleural effusion is a significant clinical challenge.

    Purpose of the Study:

    • To evaluate the efficacy and safety of intrapleural thymostimulin (TS) for treating neoplastic pleural effusion.
    • To assess the potential of TS as a palliative treatment for malignant pleural effusions.
    • To determine the response rate and duration of remission in patients receiving intrapleural TS.

    Main Methods:

    • A preliminary trial involving twelve patients with neoplastic pleural effusion.

    Related Experiment Videos

  • Intrapleural administration of thymostimulin (TS) at a mean dose of 140 mg (2 mg/kg).
  • Inclusion of patients with mesothelioma, breast carcinoma metastases, lung epidermoid, lung adenocarcinoma, uterine carcinoma, and ovarian carcinoma.

    • Main Results:

    • Complete remission was achieved in 4 patients within 3 weeks and an additional 4 patients within 8 weeks.
    • Thymostimulin (TS) treatment was effective in 11 out of 12 patients, with mesothelioma being the only resistant case.
    • The intrapleural treatment demonstrated rapid and efficient palliation without significant toxic procedures.

    Conclusions:

    • Intrapleural thymostimulin (TS) is a promising therapeutic option for palliative treatment of neoplastic pleural effusion.
    • This approach offers a rapid, efficient, and well-tolerated method for managing malignant pleural effusions.
    • Further investigation is warranted to confirm these findings in larger patient cohorts.